Key result
WHOQOL-BREF four-domain subtests demonstrate valid Rasch model fit and satisfactory reliability.
Why the study?
The psychometric properties of the Thai WHOQOL-BREF and its shorter versions in patients undergoing warfarin treatment had not been evaluated using Rasch analysis.
Cross-Sectional (n=260)
Yes
Effect estimate: χ2[16] = 12.26
p-value: p=0.73
The Thai WHOQOL-BREF four-domain subtest is a reliable and valid instrument for measuring health-related quality of life in patients undergoing warfarin therapy.
May support QoL assessment with WHOQOL-BREF in Thai warfarin patients; extends Rasch validation to this population.
Rasch analysis was employed to investigate the psychometric properties of the World Health Organization Quality of Life-BREF (WHOQOL-BREF) and its shorter versions (EUROHIS-QOL-8 and WHOQOL-5) within the context of patients undergoing warfarin in Thailand. A group of 260 patients were recruited from three public hospitals and tasked with completing the WHOQOL-BREF questionnaire. Rasch analysis showed that the WHOQOL-BREF, structured into four-domain subtests, achieved a commendable fit to the Rasch model (χ 2 [16] = 12.26, p = 0.73), met the criterion of unidimensionality (7.31% significant t -tests; lower bound confidence interval, 4.66), and demonstrated satisfactory reliability (PSI = 0.87). The adoption of a subtest approach facilitated an acceptable fit to the Rasch model for each domain of the WHOQOL-BREF, except for the social domain. However, the presence of local dependency of the three-item social domain was detected, so the reliability was not reported. The WHOQOL-5 proved to be unidimensional, fitting the Rasch model acceptably, and had satisfactory reliability. Conversely, the EUROHIS-QOL-8 presented local dependency; thus, reliability was not reported. Consequently, the WHOQOL-BREF in its four-domain subtests is recommended for pre- and post-HRQoL measurements, whereas the WHOQOL-5 can effectively measure HRQoL levels in between-group analyses.
No takes yet. Share an insight, caveat, or question.
Kangwanrattanakul et al. (2024) conducted a cross-sectional in Patients undergoing warfarin treatment (n=260). WHOQOL-BREF and shorter versions (EUROHIS-QOL-8, WHOQOL-5) was evaluated on Fit to the Rasch model for the WHOQOL-BREF four-domain subtests (χ2[16] = 12.26, p=0.73). The WHOQOL-BREF structured into four-domain subtests achieved a commendable fit to the Rasch model (χ2[16] = 12.26, p = 0.73) and demonstrated satisfactory reliability (PSI = 0.87).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: